Dr. Rohan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
11000 E 45th Ave
Denver, CO 80239Phone+1 303-338-4545Fax+1 303-899-6999
Education & Training
- Memorial Sloan Kettering Cancer Center Oncologic PathologyFellowship, Selective Pathology, 2007 - 2008
- New York Presbyterian Hospital (Cornell Campus)Residency, Pathology-Anatomic and Clinical, 2003 - 2007
- Medical College of WisconsinClass of 2003
Certifications & Licensure
- MO State Medical License 2024 - 2026
- WA State Medical License 2024 - 2026
- AL State Medical License 2024 - 2025
- CO State Medical License 2014 - 2025
- GA State Medical License 2024 - 2025
- KS State Medical License 2019 - 2025
- MT State Medical License 2023 - 2025
- American Board of Pathology Pathology - Anatomic/Pathology - Clinical
- Join now to see all
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
Publications & Presentations
PubMed
- 8 citationsCytomorphology, immunoprofile, and management of renal oncocytic neoplasms.Bing Zhu, Stephen M. Rohan, Xiaoqi Lin
Cancer Cytopathology. 2020-12-01 - 58 citationsThe classification of pediatric and young adult renal cell carcinomas registered on the children's oncology group (COG) protocol AREN03B2 after focused genetic testing.Mariana M. Cajaiba, Lisa M. Dyer, James I. Geller, Lawrence J. Jennings, David George
Cancer. 2018-08-15 - 68 citationsPatient-Derived Tumor Xenografts Are Susceptible to Formation of Human Lymphocytic Tumors.Gennadiy Bondarenko, Andrey Ugolkov, Stephen M. Rohan, Piotr Kulesza, Oleksii Dubrovskyi
Neoplasia. 2015-09-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: